Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delmed was a medical technology and pharmaceutical company that specialized in the development and manufacture of products for peritoneal dialysis and blood banking. Founded in 1975, the company became a significant player in the nephrology market, particularly through its innovations in Continuous Ambulatory Peritoneal Dialysis (CAPD) systems. Delmed's product portfolio included sterile plastic bags, intravenous solutions, and specialized dialysis fluids such as Del-Flex. The company's growth was characterized by a strategic partnership with the German healthcare giant Fresenius, which sought to expand its footprint in the U.S. dialysis market. This relationship culminated in Fresenius acquiring a controlling interest in Delmed in 1990, eventually leading to the full integration of its technologies into Fresenius Medical Care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delmed.